Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
Related structures:
AlphaFold database: A0A3S7WZX6
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 14 |
GO:0006665 | sphingolipid metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0008610 | lipid biosynthetic process | 4 | 14 |
GO:0009058 | biosynthetic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 14 |
GO:0044255 | cellular lipid metabolic process | 3 | 14 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 14 |
GO:1901576 | organic substance biosynthetic process | 3 | 14 |
GO:0006672 | ceramide metabolic process | 4 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043603 | amide metabolic process | 3 | 2 |
GO:0043604 | amide biosynthetic process | 4 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046513 | ceramide biosynthetic process | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016491 | oxidoreductase activity | 2 | 14 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 14 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4 | 14 |
GO:0042284 | sphingolipid delta-4 desaturase activity | 5 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 112 | 116 | PF00656 | 0.292 |
CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.295 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.254 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.346 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.527 |
DOC_CKS1_1 | 22 | 27 | PF01111 | 0.320 |
DOC_CKS1_1 | 73 | 78 | PF01111 | 0.488 |
DOC_CYCLIN_yCln2_LP_2 | 22 | 28 | PF00134 | 0.364 |
DOC_CYCLIN_yCln2_LP_2 | 88 | 94 | PF00134 | 0.303 |
DOC_MAPK_gen_1 | 152 | 161 | PF00069 | 0.461 |
DOC_MAPK_MEF2A_6 | 20 | 29 | PF00069 | 0.288 |
DOC_MAPK_MEF2A_6 | 38 | 47 | PF00069 | 0.240 |
DOC_PP1_RVXF_1 | 105 | 112 | PF00149 | 0.278 |
DOC_PP1_RVXF_1 | 150 | 157 | PF00149 | 0.461 |
DOC_PP1_RVXF_1 | 327 | 334 | PF00149 | 0.549 |
DOC_PP2B_LxvP_1 | 88 | 91 | PF13499 | 0.303 |
DOC_PP4_FxxP_1 | 73 | 76 | PF00568 | 0.499 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.565 |
DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.320 |
DOC_WW_Pin1_4 | 72 | 77 | PF00397 | 0.488 |
LIG_14-3-3_CanoR_1 | 125 | 131 | PF00244 | 0.302 |
LIG_14-3-3_CanoR_1 | 265 | 270 | PF00244 | 0.553 |
LIG_Actin_WH2_2 | 134 | 149 | PF00022 | 0.405 |
LIG_AP2alpha_2 | 16 | 18 | PF02296 | 0.500 |
LIG_BRCT_BRCA1_1 | 204 | 208 | PF00533 | 0.484 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.289 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.293 |
LIG_FHA_1 | 42 | 48 | PF00498 | 0.327 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.444 |
LIG_FHA_2 | 118 | 124 | PF00498 | 0.247 |
LIG_FHA_2 | 270 | 276 | PF00498 | 0.452 |
LIG_FXI_DFP_1 | 238 | 242 | PF00024 | 0.226 |
LIG_KLC1_Yacidic_2 | 258 | 262 | PF13176 | 0.582 |
LIG_LIR_Apic_2 | 218 | 224 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 138 | 146 | PF02991 | 0.296 |
LIG_LIR_Gen_1 | 153 | 164 | PF02991 | 0.526 |
LIG_LIR_Gen_1 | 24 | 33 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 272 | 282 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 59 | 67 | PF02991 | 0.290 |
LIG_LIR_Gen_1 | 75 | 86 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 16 | 21 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 194 | 199 | PF02991 | 0.321 |
LIG_LIR_Nem_3 | 217 | 222 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 24 | 29 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 240 | 244 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 258 | 263 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 272 | 277 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.190 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.445 |
LIG_NRBOX | 183 | 189 | PF00104 | 0.405 |
LIG_Pex14_1 | 181 | 185 | PF04695 | 0.278 |
LIG_Pex14_1 | 230 | 234 | PF04695 | 0.461 |
LIG_Pex14_2 | 135 | 139 | PF04695 | 0.282 |
LIG_Pex14_2 | 177 | 181 | PF04695 | 0.374 |
LIG_PTB_Apo_2 | 228 | 235 | PF02174 | 0.526 |
LIG_PTB_Apo_2 | 76 | 83 | PF02174 | 0.461 |
LIG_PTB_Phospho_1 | 228 | 234 | PF10480 | 0.526 |
LIG_PTB_Phospho_1 | 76 | 82 | PF10480 | 0.478 |
LIG_SH2_CRK | 222 | 226 | PF00017 | 0.426 |
LIG_SH2_PTP2 | 260 | 263 | PF00017 | 0.578 |
LIG_SH2_STAP1 | 82 | 86 | PF00017 | 0.312 |
LIG_SH2_STAP1 | 94 | 98 | PF00017 | 0.278 |
LIG_SH2_STAT3 | 164 | 167 | PF00017 | 0.320 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.236 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 260 | 263 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.257 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.310 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.436 |
LIG_SH3_3 | 87 | 93 | PF00018 | 0.301 |
LIG_SUMO_SIM_anti_2 | 44 | 49 | PF11976 | 0.404 |
LIG_TRFH_1 | 144 | 148 | PF08558 | 0.332 |
LIG_TRFH_1 | 276 | 280 | PF08558 | 0.563 |
LIG_TYR_ITIM | 183 | 188 | PF00017 | 0.344 |
LIG_WRC_WIRS_1 | 136 | 141 | PF05994 | 0.285 |
LIG_WRC_WIRS_1 | 188 | 193 | PF05994 | 0.405 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.609 |
MOD_CK2_1 | 117 | 123 | PF00069 | 0.247 |
MOD_CMANNOS | 178 | 181 | PF00535 | 0.404 |
MOD_CMANNOS | 227 | 230 | PF00535 | 0.247 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.431 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.289 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.527 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.364 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.439 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.303 |
MOD_N-GLC_1 | 280 | 285 | PF02516 | 0.366 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.307 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.281 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.512 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.553 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.273 |
MOD_PKA_2 | 146 | 152 | PF00069 | 0.461 |
MOD_PKA_2 | 291 | 297 | PF00069 | 0.576 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.524 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.480 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.321 |
MOD_Plk_4 | 269 | 275 | PF00069 | 0.434 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.263 |
MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.320 |
MOD_ProDKin_1 | 72 | 78 | PF00069 | 0.488 |
MOD_SUMO_for_1 | 154 | 157 | PF00179 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 179 | 184 | PF01217 | 0.344 |
TRG_ENDOCYTIC_2 | 185 | 188 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.427 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.486 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.311 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.236 |
TRG_Pf-PMV_PEXEL_1 | 107 | 112 | PF00026 | 0.478 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P225 | Leptomonas seymouri | 84% | 95% |
A0A0S4IWE2 | Bodo saltans | 50% | 100% |
A0A0S4IZS1 | Bodo saltans | 50% | 98% |
A0A1X0NG21 | Trypanosomatidae | 69% | 97% |
A0A1X0P7H0 | Trypanosomatidae | 69% | 97% |
A0A3S5H7G4 | Leishmania donovani | 100% | 100% |
A4HD58 | Leishmania braziliensis | 85% | 100% |
A4I2A2 | Leishmania infantum | 99% | 100% |
C4R613 | Komagataella phaffii (strain GS115 / ATCC 20864) | 41% | 93% |
C9ZQX1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 97% |
E8NHH2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9AYE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
G5EC63 | Caenorhabditis elegans | 41% | 93% |
O09005 | Mus musculus | 41% | 100% |
O15121 | Homo sapiens | 43% | 100% |
O44186 | Caenorhabditis elegans | 41% | 93% |
O59715 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 45% | 93% |
Q0II71 | Bos taurus | 44% | 100% |
Q3ZBY7 | Bos taurus | 42% | 100% |
Q4Q923 | Leishmania major | 96% | 100% |
Q4Q925 | Leishmania major | 97% | 100% |
Q564G3 | Rattus norvegicus | 42% | 100% |
Q5AJX2 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 45% | 91% |
Q5F3C1 | Gallus gallus | 40% | 100% |
Q5RE51 | Pongo abelii | 42% | 100% |
Q5XIF5 | Rattus norvegicus | 42% | 100% |
Q68FB8 | Xenopus tropicalis | 42% | 100% |
Q6H5U3 | Oryza sativa subsp. japonica | 43% | 100% |
Q6QHC5 | Homo sapiens | 44% | 100% |
Q6UQ04 | Microtus fortis | 41% | 100% |
Q8R2F2 | Mus musculus | 42% | 100% |
Q94515 | Drosophila melanogaster | 44% | 100% |
Q9ZPH4 | Arabidopsis thaliana | 42% | 100% |
V5DBA3 | Trypanosoma cruzi | 68% | 97% |